公开(公告)号：US20140065100A1

公开(公告)日：2014-03-06

申请号：US14075130

申请日：2013-11-08

Applicant: Eisai R&D Management Co., Ltd.

Inventor： Daniel P. Rossignol ,  Sally T. Ishizaka ,  Lynn D. Hawkins ,  Scott Fields

IPC: A61K39/00 ,  A61K45/06

CPC classification number: A61K39/0011 ,  A61K45/06 ,  A61K2039/55511

Abstract: The invention relates to immunotherapeutic compounds and to methods for stimulating an immune response in a subject individual at risk for developing cancer, diagnosed with a cancer, in treatment for cancer, or in post-therapy recovery from cancer or the compounds of the invention can be administered as a prophylactic to a subject individual to prevent or delay the development of cancer.

Abstract translation: 本发明涉及免疫治疗化合物以及用于在患有癌症，癌症诊断，癌症治疗或癌症治疗后恢复的危险中的受试个体中刺激免疫应答的方法或本发明的化合物可以是 作为对个体进行预防以预防或延缓癌症的发展。